Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 6/20 | 0.42 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.41 |
| ▸ | GAPDH | P04406 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15786369 | 0.88 | P2RY12 (0.38) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL23953078 | 0.83 | TYMP (0.41) | P2RY12P2RY1 | |
| SCHEMBL11055621 | 0.81 | P2RY12 (0.40) | P2RY12POLB | |
| SCHEMBL17860496 | 0.81 | TYMP (0.42) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL4730470 | 0.81 | TYMP (0.45) | P2RY12GAPDH | |
| SCHEMBL17860588 | 0.80 | ADORA1 (0.40) | P2RY12P2RY1P2RY2P2RY6POLB | |
| SCHEMBL5694262 | 0.80 | P2RY12 (0.37) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL21417334 | 0.79 | TYMP (0.41) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL20341092 | 0.79 | P2RY12 (0.39) | P2RY12P2RY1P2RY2P2RY6 | |
| SCHEMBL21044306 | 0.79 | TYMP (0.58) | P2RY12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140163037-A1 | SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS | TRANA DISCOVERY, INC. (US) | 2014-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140163037-A1 | SCREENING METHODS FOR IDENTIFYING SPECIFIC STAPHYLOCOCCUS AUREUS INHIBITORS | NSUN3, RNGTT, TRMT1 | P2RY12 4640/4885P2RY1 4734/4885P2RY2 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.